Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, December 22, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
People on the Move
Myonex Names Greg Lavin as Chief Executive Officer
Life Sciences Times
-
November 20, 2025
0
Biotech
Valo Health Forms Strategic Collaboration with Merck KGaA, Darmstadt, Germany to Advance Parkinson’s Disease Drug Discovery
Life Sciences Times
-
November 20, 2025
0
Technology
ConcertAI Launches TeraRecon AV to Advance AI-Driven Medical Imaging
Life Sciences Times
-
November 20, 2025
0
Biotech
Paradromics Gains FDA Approval to Launch Connect-One Study of Connexus Brain-Computer Interface
Life Sciences Times
-
November 20, 2025
0
Technology
AI Model Pillar-0 Raises Diagnostic Bar in Medical Imaging
Life Sciences Times
-
November 20, 2025
0
Medtech
VenstraMedical Secures Investment From Highcroft Capital to Advance Next-Generation Cardiac Support Device
Life Sciences Times
-
November 19, 2025
0
Venture Capital
Profluent Raises $106 Million to Scale Frontier AI Models for Programmable Biology
Life Sciences Times
-
November 19, 2025
0
Technology
Synthio Labs Raises $5 Million to Build Voice AI Operating System for Life Sciences Engagement
Life Sciences Times
-
November 19, 2025
0
Venture Capital
AI Proteins Raises $41.5 Million Series A to Advance De Novo Miniprotein Medicines
Life Sciences Times
-
November 19, 2025
0
Biotech
Boston Cell Standards: Calibration Improves Accuracy in HER2-Low Breast Cancer Testing
Life Sciences Times
-
November 19, 2025
0
1
...
13
14
15
...
773
Page 14 of 773
Most Popular
Manifold Raises $18 Million Series B to Expand Vertical AI Platform for Life Sciences
December 19, 2025
PureTech Appoints Robert Lyne as Chief Executive Officer
December 19, 2025
Orum Therapeutics Raises Approximately $100 Million to Advance Degrader Antibody Conjugate Programs
December 19, 2025
Syremis Therapeutics Launches With $165 Million Series A to Advance New Treatments for Mental Health Disorders
December 19, 2025
Load more
Recent Comments
Recent Comments